Rockwell Medical, Inc.
RMTI
$1.10
-$0.03-2.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.64% | 19.12% | 42.88% | 15.29% | 14.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.64% | 19.12% | 42.88% | 15.29% | 14.39% |
| Cost of Revenue | 9.42% | 2.36% | 24.84% | 14.90% | 13.26% |
| Gross Profit | 26.52% | 183.33% | 340.46% | 17.89% | 22.65% |
| SG&A Expenses | 27.70% | 24.91% | 5.49% | 16.60% | -21.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.24% | 3.42% | 20.33% | 13.77% | 6.40% |
| Operating Income | 5.12% | 211.46% | 117.40% | 7.22% | 72.18% |
| Income Before Tax | 50.00% | 188.89% | 110.38% | 1.09% | 35.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 50.00% | 188.89% | 110.38% | 1.09% | 35.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.00% | 188.89% | 110.38% | 1.09% | 35.99% |
| EBIT | 5.12% | 211.46% | 117.40% | 7.22% | 72.18% |
| EBITDA | 700.00% | 311.34% | 138.15% | 38.52% | 100.17% |
| EPS Basic | 46.55% | 166.76% | 104.78% | 57.68% | 71.64% |
| Normalized Basic EPS | 57.95% | 169.47% | 104.88% | 57.63% | 72.46% |
| EPS Diluted | 44.01% | 157.14% | 104.78% | 56.96% | 71.00% |
| Normalized Diluted EPS | 57.95% | 167.58% | 104.63% | 57.63% | 72.46% |
| Average Basic Shares Outstanding | 14.75% | 14.65% | 81.31% | 133.63% | 148.08% |
| Average Diluted Shares Outstanding | 14.75% | 17.80% | 90.73% | 133.63% | 148.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |